US Patent 11242375 Immune cell compositions and methods of use
Patent 11242375 was granted and assigned to Memorial Sloan Kettering Cancer Center on February, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11242375 Immune cell compositions and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
